The Injection Lab is brought to you by embecta, a company dedicated to improving the injection experience for people living with diabetes around the world. For over a century, embecta has been committed to advancing diabetes care through innovation, education, and patient support.
Our goal is to make every injection safe, simple, and more consistent — because when people feel confident in their technique, they can focus more on living their lives.
embecta has been advancing injection science since developing the first insulin syringe in 1924.
References
1. Bari B, Corbeil MA, Farooqui H, et al. Insulin injection practices in a population of Canadians with diabetes: an observational study. Diabetes Ther. 2020;11(11):2595–2609. 2. Frid AH, Kreugel G, Grassi G, et al. New insulin delivery recommendations. Mayo Clin Proc. 2016;91(9):1231–1255. 4. Misnikova IV, Gubkina VA, Lakeeva TS, Dreval AV. A randomized controlled trial to assess the impact of proper insulin injection technique training on glycemic control. Diabetes Ther. 2017;8(6):1309–1318. 5. Grassi G, Scuntero P, Trepiccioni R, Marubbi F, Strauss K. Optimizing insulin injection technique and its effect on blood glucose control. J Clin Transl Endocrinol. 2014;1(4):145–150. 6. Gibney MA, Arce CH, Byron KJ, Hirsch LJ. Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations. Curr Med Res Opin. 2010;26(6):1519–1530. 7. Klonoff DC, Berard L, Franco DR, et al. Advance insulin injection technique and education with FITTER Forward expert recommendations. Mayo Clin Proc. 2025. 8. Blanco M, Hernández MT, Strauss KW, Amaya M. Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes. Diabetes Metab. 2013;39(5):445–453. 9. Frid AH, Hirsch LJ, Menchior AR, et al. Worldwide injection technique questionnaire study: injecting complications and the role of the professional. Mayo Clin Proc. 2016;91(9):1224–1230. 10. Frid AH, Hirsch LJ, Grassi G, et al. Worldwide injection technique questionnaire study: population parameters and injection practices. Mayo Clin Proc. 2016;91(9):1212–1223. doi:10.1016/j.mayocp.2016.06.011 11. Hirsch LJ, Gibney MA, Berube J, Manocchio J. Impact of a modified needle tip geometry on penetration force and perceived pain in subjects with diabetes. J Diabetes Sci Technol. 2012;6(2):328–335. 12. Rini C, Roberts BC, Morel D, et al. Evaluating the impact of human factors and pen needle design on insulin pen injection. J Diabetes Sci Technol. 2019;13(3):533–545. 13. Aronson R, Gibney MA, Oza K, Bérubé J, Kassler-Taub K, Hirsch L. Insulin pen needles: effects of extra-thin wall needle technology on preference, confidence, and other patient ratings. Clin Ther. 2013;35(7):923-933.e4. doi:10.1016/j.clinthera.2013.05.020 14. Stainless steel needle tubing for the manufacture of medical devices—requirements and test methods. ISO 9626. 2016. 15. Whooley S, Briskin T, Gibney MA, Blank LR, Bérubé J, Pflug BK. Evaluating the user performance and experience with a reengineered 4 mm 32G pen needle: a randomized trial with similar length/gauge needles. Diabetes Ther. 2019;10(2):697–712. 16. American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes—2026. Diabetes Care. 2026;49(Suppl 1):S1-S350. doi:10.2337/dc26-SINT.